118 related articles for article (PubMed ID: 3953293)
1. The immediate haemodynamic and electrophysiological response to prenalterol during fixed rate pacing in patients with chronic ischaemic heart disease.
Sire S; Amlie JP; Simonsen S
Acta Pharmacol Toxicol (Copenh); 1986 Jan; 58(1):43-8. PubMed ID: 3953293
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
Erbel R; Meyer J; Schweizer P; Lambertz H; Voelker W; Effert S
Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
[TBL] [Abstract][Full Text] [Related]
3. Influence of heart rate on the effects of prenalterol on regional myocardial blood flow and function during coronary stenosis in dogs.
Berdeaux A; Bonhenry C; Duhazé P; Giudicelli JF; Thuillez C
Br J Pharmacol; 1984 Sep; 83(1):203-10. PubMed ID: 6148979
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic effects of prenalterol in patients with coronary heart disease.
Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic effects of prenalterol in acute myocardial ischaemia in open chest pigs.
Branzi A; Binetti G; Specchia S; Magelli C; Zannoli R; Magnani B
Clin Exp Pharmacol Physiol; 1983; 10(3):219-27. PubMed ID: 6627738
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of atrial pacing and prenalterol infusion in patients taking beta-adrenergic blocking drugs.
Shiu MF; Ireland MA; Littler WA
Circulation; 1981 Dec; 64(6):1135-41. PubMed ID: 6117380
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure.
Kupper W; Schütt M; Bleifeld W
Acta Med Scand Suppl; 1982; 659():287-98. PubMed ID: 6127895
[TBL] [Abstract][Full Text] [Related]
8. Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
Svendsen TL; Carlsen JE; Hartling OJ; Trap-Jensen J
Clin Physiol; 1981 Oct; 1(5):461-9. PubMed ID: 7199993
[TBL] [Abstract][Full Text] [Related]
9. The haemodynamic effects of dopamine and prenalterol in patients after cardiac valve surgery.
Tydén H; Johansson L; Nyström SO
Acta Anaesthesiol Scand; 1982 Oct; 26(5):468-73. PubMed ID: 6128857
[TBL] [Abstract][Full Text] [Related]
10. Effects of prenalterol on cardiac performance and transmural myocardial perfusion in patients with chronic renal failure.
Pedersen T; Cleemann-Rasmussen K; Brynjolf I; Ording H; Nielsen PE; Rasmussen K
Eur J Clin Pharmacol; 1983; 25(3):287-92. PubMed ID: 6628515
[TBL] [Abstract][Full Text] [Related]
11. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
Kupper W; Schütt M; Hamm CW; Kuck KH; Hanrath P; Bleifeld W
Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic effects of intravenously administered prenalterol in patients with severe heart failure.
Waagstein F; Estrada-Yamamoto M; Reiz S; Reyes C; Hjalmarson A
Acta Med Scand Suppl; 1982; 659():221-31. PubMed ID: 6127891
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic and myocardial metabolic effects of the beta-agonist prenalterol in ischemic left ventricular dysfunction.
Kirlin PC; Walton JA; Brymer JF; Beauman G; Pitt B
J Cardiovasc Pharmacol; 1984; 6(5):852-8. PubMed ID: 6209491
[TBL] [Abstract][Full Text] [Related]
14. The haemodynamic effects of intravenous prenalterol and ouabain in conscious dogs.
Ek L; Björkman JA; Carlsson E; Johansson B
Acta Med Scand Suppl; 1982; 659():39-52. PubMed ID: 6127899
[TBL] [Abstract][Full Text] [Related]
15. Inotropic, chronotropic and dromotropic effects of prenalterol, a new cardiostimulant drug.
Moore EN; Aberg G; Spear JF; Hodess AB; Herrmann I; Adler G
Acta Med Scand Suppl; 1982; 659():53-70. PubMed ID: 6958179
[TBL] [Abstract][Full Text] [Related]
16. Intravenous and oral prenalterol in congestive heart failure. Effects on systemic and coronary hemodynamics and myocardial catecholamine balance.
Wahr DW; Swedberg K; Rabbino M; Hoyle MJ; Curran D; Parmley WW; Chatterjee K
Am J Med; 1984 Jun; 76(6):999-1005. PubMed ID: 6731471
[TBL] [Abstract][Full Text] [Related]
17. Contractile, coronary, and metabolic effects of the acute and long-term treatment of cardiac failure with prenalterol.
Strauer BE; Bohn I; Hahn B; Kment A; Motz U
J Cardiovasc Pharmacol; 1984; 6(3):491-8. PubMed ID: 6202977
[TBL] [Abstract][Full Text] [Related]
18. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
[TBL] [Abstract][Full Text] [Related]
19. Effect of prenalterol on contractility, relaxation, and filling phase in coronary artery disease patients with previous myocardial infarction.
Cucchini F; Baldi G; Bolognesi R; Ferrari R; Visioli O
J Cardiovasc Pharmacol; 1984; 6(5):822-8. PubMed ID: 6209486
[TBL] [Abstract][Full Text] [Related]
20. The effects of intravenous prenalterol on ventricular performance, as assessed by radionuclide ventriculography, in patients with ischaemic heart disease.
Muir AL; Hannan WJ; Dewhurst NG; Slessor IM
Br J Clin Pharmacol; 1981 Oct; 12(4):475-80. PubMed ID: 7295483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
